Leukemia

Results: 2453



#Item
1MDACC LEUKEMIA AND LYMPHOMA Europe and the USA Linking Knowledge and Practice

MDACC LEUKEMIA AND LYMPHOMA Europe and the USA Linking Knowledge and Practice

Add to Reading List

Source URL: www.hematology.cz

Language: English - Date: 2018-05-28 07:58:44
    2Genome-wide mapping of proviral integration sites in aggresive virus-induced leukemia Nicolas Rosewick1,2, Vincent Hahaut1, Maria Artesi1, Keith Durkin1, Ambroise Marçais3, Philip Griebel4, Natasa Arsic4, Véronique Ave

    Genome-wide mapping of proviral integration sites in aggresive virus-induced leukemia Nicolas Rosewick1,2, Vincent Hahaut1, Maria Artesi1, Keith Durkin1, Ambroise Marçais3, Philip Griebel4, Natasa Arsic4, Véronique Ave

    Add to Reading List

    Source URL: www.user2017.brussels

    Language: English - Date: 2017-06-21 06:05:21
      3Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells Lijuan Xia, Duo Chen, Rui Han, et al. Mol Cancer Ther 2005;4:Updated version

      Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells Lijuan Xia, Duo Chen, Rui Han, et al. Mol Cancer Ther 2005;4:Updated version

      Add to Reading List

      Source URL: www.adonito.com

      Language: English - Date: 2016-10-13 12:28:13
        4The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2

        The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2

        Add to Reading List

        Source URL: glycomimetics.com

        Language: English - Date: 2016-12-12 15:22:04
          5A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan

          A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan

          Add to Reading List

          Source URL: glycomimetics.com

          Language: English - Date: 2016-12-05 13:18:26
            6Platelet Proteomics in Chronic Myeloid Leukemia

            Platelet Proteomics in Chronic Myeloid Leukemia

            Add to Reading List

            Source URL: www.scireslit.com

            Language: English - Date: 2017-06-20 12:15:40
              7Case Study: Challenge: How to profile Leukemia & Lymphoma Society

              Case Study: Challenge: How to profile Leukemia & Lymphoma Society

              Add to Reading List

              Source URL: www.newsusaadvantage.com

              Language: English - Date: 2017-10-23 15:28:31
                8NEWS RELEASE For Immediate Release Taking it to Church: Enhancing Myeloma Knowledge and Access to Latest Treatments To Address Health Disparities in African American Communities -The Leukemia & Lymphoma Society Launches

                NEWS RELEASE For Immediate Release Taking it to Church: Enhancing Myeloma Knowledge and Access to Latest Treatments To Address Health Disparities in African American Communities -The Leukemia & Lymphoma Society Launches

                Add to Reading List

                Source URL: www.naltblackchurch.com

                Language: English - Date: 2017-07-24 10:25:43
                  9

                  Assay Container Preservative/Medium Quantity Storage/Transportation Leukemia/Lymphoma: Peripheral Blood 5mL tube EDTA, sodium heparin, or ACD 5mL (adults); 1mL (children) Room TempC) < 24 hrs old Leukemia/Lymph

                  Add to Reading List

                  Source URL: pathology.uthscsa.edu

                  Language: English - Date: 2011-12-20 16:33:56
                    10Guardians of Research New breakthroughs in childhood leukemia Siteman Kids at St. Louis Children’s Hospital is among the first to offer breakthrough cancer treatment that turns a child’s

                    Guardians of Research New breakthroughs in childhood leukemia Siteman Kids at St. Louis Children’s Hospital is among the first to offer breakthrough cancer treatment that turns a child’s

                    Add to Reading List

                    Source URL: www.childrensdiscovery.org

                    Language: English - Date: 2018-03-19 14:03:50